Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2918.2518.65 (+0.64 %)
PREV CLOSE () 2899.60
OPEN PRICE () 2897.85
BID PRICE (QTY) 2917.30 (54)
OFFER PRICE (QTY) 2919.80 (25)
VOLUME 3047
TODAY'S LOW / HIGH ()2871.05 2951.00
52 WK LOW / HIGH ()2088 3051
NSE2921.7019.5 (+0.67 %)
PREV CLOSE() 2902.20
OPEN PRICE () 2875.10
BID PRICE (QTY) 2920.10 (1)
OFFER PRICE (QTY) 2921.60 (5)
VOLUME 69339
TODAY'S LOW / HIGH() 2865.40 2955.90
52 WK LOW / HIGH ()2088.1 3054.9
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1924

Management Info :

R S Karnad - Chairman Bhushan Akshikar - Managing Director

Registered Office :

Address : 252, Gsk House,Dr. Annie Besant Road,Worli,
Mumbai,
Maharashtra-400030

Phone : 022-24959595

Website : www.gsk-india.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
21Jul GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulations 29 & 33 of the Listing Obligations and Discl..
25Jun GlaxoSmithKline Pharmaceuticals infor
GlaxoSmithKline Pharmaceuticals has informed that the Company has receiv..
08Jun GlaxoSmithKline Pharmaceuticals inf
In terms of the requirements of Regulation 36(1)(b) of the SEBI (Listing..
26May GlaxoSmithKline Pharmaceuticals infor
In compliance with the provisions of Regulation 24A of SEBI LODR Amendme..
21Apr GlaxoSmithKline Pharmaceuticals inform
In compliance with Regulation 30 of Securities and Exchange Board of Ind..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit2533.310118.2
Gross Profit 3379.8 13762.3
Operating Profit 3547.914427.6
Net Sales 9244.237902
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Kwality Pharma (BSE)
 3455.90 (2.94%)
M.Cap ( in Cr)
3584.87
Bharat Parenterals (BSE)
 1451.05 (4.93%)
M.Cap ( in Cr)
1000.02
Glenmark Pharma. (BSE)
 2373.00 (2.91%)
M.Cap ( in Cr)
66825.16
Orchid Pharma (BSE)
 1044.10 (4.68%)
M.Cap ( in Cr)
6214.59
Shilpa Medicare (BSE)
 850.15 (4.38%)
M.Cap ( in Cr)
16530.58
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 12.41%
MUTUAL FUNDS/UTI 4.87%
FI/BANKS/INSURANCE 2.79%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77247.68-293.15 (-0.38%)
NIFTY24171.85-80.15 (-0.33%)
Dow Jones 53277.01517.80 (0.98%)
Nasdaq 26180.46113.29 (0.43%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI